Literature DB >> 32238303

Clinical-radiomics Nomogram for Risk Estimation of Early Hematoma Expansion after Acute Intracerebral Hemorrhage.

Qian Chen1, Dongqin Zhu1, Jinjin Liu1, Mingyue Zhang1, Haoli Xu1, Yilan Xiang1, Chenyi Zhan1, Yong Zhang2, Shengwei Huang3, Yunjun Yang4.   

Abstract

RATIONALE AND
OBJECTIVES: Noncontrast CT-based radiomics signature has shown ability for detecting hematoma expansion (HE) in spontaneous intracerebral hemorrhage (ICH). We sought to compare its predictive performance with clinical risk factors and develop a clinical-radiomics nomogram to assess the risk of early HE.
MATERIALS AND METHODS: In total, 1153 patients with ICH who underwent baseline cranial CT within 6 hours and follow-up scans within 72 hours of stroke onset were enrolled, of whom 864 (75%) were assigned to the derivation cohort and 289 (25%) to the validation cohort. Based on LASSO algorithm or stepwise logistic regression analysis, three models (clinical model, radiomics model, and hybrid model) were constructed to predict HE. The Akaike information criterion (AIC) and likelihood ratio test (LRT) were used for comparing the goodness of fit of the three models, and the AUC was used to evaluate their discrimination ability for HE.
RESULTS: The hybrid model (AIC = 681.426; χ2= 128.779) was the optimal model with the lowest AIC and highest chi-square values compared to the radiomics model (AIC = 767.979; χ2 = 110.234) or the clinical model (AIC = 753.757; χ2 = 56.448). The radiomics model was superior in the prediction of HE to the clinical model in both derivation (p = 0.009) and validation (p = 0.022) cohorts. In both datasets, the clinical-radiomics nomogram showed satisfactory discrimination and calibration for detecting HE (AUC = 0.771, Sensitivity = 87.0%; AUC = 0.820, Sensitivity = 88.1%; respectively).
CONCLUSION: Among patients with acute ICH, noncontrast CT-based radiomics model outperformed the clinical-only model in the prediction of HE, and the established clinical-radiomics nomogram with favorable performance can offer a noninvasive tool for the risk stratification of HE.
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical risk factor; Computed tomography; Intracerebral hemorrhage expansion; Nomogram; Radiomics analysis

Mesh:

Year:  2020        PMID: 32238303     DOI: 10.1016/j.acra.2020.02.021

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  11 in total

1.  Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer.

Authors:  Feng Lin; Li Lan; Fei Yao; Jie Ding; Zhangyong Hu; Mengting Cai; Jinjin Liu; Xiaowan Huang; Ruru Zheng
Journal:  Abdom Radiol (NY)       Date:  2021-06-13

Review 2.  Can Artificial Intelligence Be Applied to Diagnose Intracerebral Hemorrhage under the Background of the Fourth Industrial Revolution? A Novel Systemic Review and Meta-Analysis.

Authors:  Kai Zhao; Qing Zhao; Ping Zhou; Bin Liu; Qiang Zhang; Mingfei Yang
Journal:  Int J Clin Pract       Date:  2022-02-24       Impact factor: 3.149

3.  Radiomics for intracerebral hemorrhage: are all small hematomas benign?

Authors:  Chenyi Zhan; Qian Chen; Mingyue Zhang; Yilan Xiang; Jie Chen; Dongqin Zhu; Chao Chen; Tianyi Xia; Yunjun Yang
Journal:  Br J Radiol       Date:  2020-12-17       Impact factor: 3.039

4.  The Attenuation Value Within the Non-hypodense Region on Non-contrast Computed Tomography of Spontaneous Cerebral Hemorrhage: A Long-Neglected Predictor of Hematoma Expansion.

Authors:  Yong Chen; Dan Cao; Zheng-Qian Guo; Xiao-Ling Ma; Yi-Bo Ou; Yue He; Xu Chen; Jian Chen
Journal:  Front Neurol       Date:  2022-04-08       Impact factor: 4.003

Review 5.  Emerging Applications of Radiomics in Neurological Disorders: A Review.

Authors:  Houman Sotoudeh; Amir Hossein Sarrami; Glenn H Roberson; Omid Shafaat; Zahra Sadaatpour; Ali Rezaei; Gagandeep Choudhary; Aparna Singhal; Ehsan Sotoudeh; Manoj Tanwar
Journal:  Cureus       Date:  2021-12-01

6.  Radiomics-based prediction of hemorrhage expansion among patients with thrombolysis/thrombectomy related-hemorrhagic transformation using machine learning.

Authors:  Junfeng Liu; Wendan Tao; Zhetao Wang; Xinyue Chen; Bo Wu; Ming Liu
Journal:  Ther Adv Neurol Disord       Date:  2021-11-24       Impact factor: 6.570

7.  Radiomics for predicting revised hematoma expansion with the inclusion of intraventricular hemorrhage growth in patients with supratentorial spontaneous intraparenchymal hematomas.

Authors:  Xiaona Xia; Qingguo Ren; Jiufa Cui; Hao Dong; Zhaodi Huang; Qingjun Jiang; Shuai Guan; Chencui Huang; Jihan Yin; Jingxu Xu; Kongming Liang; Hao Wang; Kai Han; Xiangshui Meng
Journal:  Ann Transl Med       Date:  2022-01

8.  Prediction of Intraparenchymal Hemorrhage Progression and Neurologic Outcome in Traumatic Brain Injury Patients Using Radiomics Score and Clinical Parameters.

Authors:  Yun-Ju Shih; Yan-Lin Liu; Jeon-Hor Chen; Chung-Han Ho; Cheng-Chun Yang; Tai-Yuan Chen; Te-Chang Wu; Ching-Chung Ko; Jonathan T Zhou; Yang Zhang; Min-Ying Su
Journal:  Diagnostics (Basel)       Date:  2022-07-10

9.  Development and validation of a nomogram to predict the 30-day mortality risk of patients with intracerebral hemorrhage.

Authors:  Jianyu Zou; Huihuang Chen; Cuiqing Liu; Zhenbin Cai; Jie Yang; Yunlong Zhang; Shaojin Li; Hongsheng Lin; Minghui Tan
Journal:  Front Neurosci       Date:  2022-08-10       Impact factor: 5.152

10.  Admission computed tomography radiomic signatures outperform hematoma volume in predicting baseline clinical severity and functional outcome in the ATACH-2 trial intracerebral hemorrhage population.

Authors:  Stefan P Haider; Adnan I Qureshi; Abhi Jain; Hishan Tharmaseelan; Elisa R Berson; Tal Zeevi; Shahram Majidi; Christopher G Filippi; Simon Iseke; Moritz Gross; Julian N Acosta; Ajay Malhotra; Jennifer A Kim; Lauren H Sansing; Guido J Falcone; Kevin N Sheth; Seyedmehdi Payabvash
Journal:  Eur J Neurol       Date:  2021-07-18       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.